Suppr超能文献

可溶性 ADAM10 和 ADAM17 金属蛋白酶的降解组。

Degradome of soluble ADAM10 and ADAM17 metalloproteases.

机构信息

Unit for Degradomics of the Protease Web, Biochemical Institute, University of Kiel, Kiel, Germany.

Systematic Proteomics and Bioanalytics, Institute for Experimental Medicine, University of Kiel, Kiel, Germany.

出版信息

Cell Mol Life Sci. 2020 Jan;77(2):331-350. doi: 10.1007/s00018-019-03184-4. Epub 2019 Jun 17.

Abstract

Disintegrin and metalloproteinases (ADAMs) 10 and 17 can release the extracellular part of a variety of membrane-bound proteins via ectodomain shedding important for many biological functions. So far, substrate identification focused exclusively on membrane-anchored ADAM10 and ADAM17. However, besides known shedding of ADAM10, we identified ADAM8 as a protease capable of releasing the ADAM17 ectodomain. Therefore, we investigated whether the soluble ectodomains of ADAM10/17 (sADAM10/17) exhibit an altered substrate spectrum compared to their membrane-bound counterparts. A mass spectrometry-based N-terminomics approach identified 134 protein cleavage events in total and 45 common substrates for sADAM10/17 within the secretome of murine cardiomyocytes. Analysis of these cleavage sites confirmed previously identified amino acid preferences. Further in vitro studies verified fibronectin, cystatin C, sN-cadherin, PCPE-1 as well as sAPP as direct substrates of sADAM10 and/or sADAM17. Overall, we present the first degradome study for sADAM10/17, thereby introducing a new mode of proteolytic activity within the protease web.

摘要

解整合素金属蛋白酶(ADAMs)10 和 17 可以通过细胞外结构域脱落释放多种膜结合蛋白的细胞外部分,这对许多生物学功能很重要。到目前为止,底物鉴定仅专注于膜锚定的 ADAM10 和 ADAM17。然而,除了已知的 ADAM10 脱落外,我们还鉴定出 ADAM8 是一种能够释放 ADAM17 细胞外结构域的蛋白酶。因此,我们研究了可溶性 ADAM10/17 (sADAM10/17)的细胞外结构域是否与它们的膜结合形式相比表现出改变的底物谱。基于质谱的 N 端组学方法总共鉴定出 134 个蛋白切割事件,以及在鼠心肌细胞分泌组中 sADAM10/17 的 45 个共同底物。对这些切割位点的分析证实了先前鉴定的氨基酸偏好。进一步的体外研究验证了纤连蛋白、半胱氨酸蛋白酶抑制剂 C、sN-钙粘蛋白、PCPE-1 以及 sAPP 是 sADAM10 和/或 sADAM17 的直接底物。总的来说,我们首次对 sADAM10/17 进行了降解组研究,从而在蛋白酶网络中引入了一种新的蛋白水解活性模式。

相似文献

1
Degradome of soluble ADAM10 and ADAM17 metalloproteases.
Cell Mol Life Sci. 2020 Jan;77(2):331-350. doi: 10.1007/s00018-019-03184-4. Epub 2019 Jun 17.
2
Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
J Biol Chem. 2016 May 13;291(20):10551-61. doi: 10.1074/jbc.M115.710541. Epub 2016 Mar 9.
3
Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17.
J Biol Chem. 2024 Jul;300(7):107480. doi: 10.1016/j.jbc.2024.107480. Epub 2024 Jun 17.
7
Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
ChemMedChem. 2018 Oct 8;13(19):2119-2131. doi: 10.1002/cmdc.201800482. Epub 2018 Sep 12.
10
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
J Biol Chem. 2017 Apr 14;292(15):6339-6351. doi: 10.1074/jbc.M116.746859. Epub 2017 Feb 23.

引用本文的文献

1
Nanobody-Targeted Conditional Antimicrobial Therapeutics.
ACS Nano. 2025 Mar 18;19(10):9958-9970. doi: 10.1021/acsnano.4c16007. Epub 2025 Mar 5.
2
Regulation of ADAM10 activity through microdomain-dependent intracellular calcium changes.
Cell Commun Signal. 2024 Nov 4;22(1):531. doi: 10.1186/s12964-024-01891-5.
3
Extracellular Release of a Disintegrin and Metalloproteinase Correlates With Periodontal Disease Severity.
J Clin Periodontol. 2025 Feb;52(2):237-248. doi: 10.1111/jcpe.14073. Epub 2024 Sep 24.
4
The mechanics of the retina: Müller glia role on retinal extracellular matrix and modelling.
Front Med (Lausanne). 2024 Sep 4;11:1393057. doi: 10.3389/fmed.2024.1393057. eCollection 2024.
6
Tim-3 Is Differentially Expressed during Cell Activation and Interacts with the LSP-1 Protein in Human Macrophages.
J Immunol Res. 2023 Oct 26;2023:3577334. doi: 10.1155/2023/3577334. eCollection 2023.
7
Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease.
Front Aging Neurosci. 2023 May 17;15:1171123. doi: 10.3389/fnagi.2023.1171123. eCollection 2023.
10
Immunomodulatory role of metalloproteinase ADAM17 in tumor development.
Front Immunol. 2022 Nov 17;13:1059376. doi: 10.3389/fimmu.2022.1059376. eCollection 2022.

本文引用的文献

1
Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.
Cell Mol Life Sci. 2019 Aug;76(16):3193-3206. doi: 10.1007/s00018-019-03179-1. Epub 2019 Jun 14.
2
Tethering soluble meprin α in an enzyme complex to the cell surface affects IBD-associated genes.
FASEB J. 2019 Jun;33(6):7490-7504. doi: 10.1096/fj.201802391R. Epub 2019 Mar 27.
3
The PRIDE database and related tools and resources in 2019: improving support for quantification data.
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
4
Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.
EMBO J. 2018 Aug 1;37(15). doi: 10.15252/embj.201899456. Epub 2018 Jul 5.
6
SWISS-MODEL: homology modelling of protein structures and complexes.
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303. doi: 10.1093/nar/gky427.
8
Extracellular matrix remodeling and cardiac fibrosis.
Matrix Biol. 2018 Aug;68-69:490-506. doi: 10.1016/j.matbio.2018.01.013. Epub 2018 Jan 31.
9
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.
Cell. 2017 Dec 14;171(7):1638-1648.e7. doi: 10.1016/j.cell.2017.11.014. Epub 2017 Dec 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验